Page last updated: 2024-08-23

etoposide and staurosporine aglycone

etoposide has been researched along with staurosporine aglycone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, RG; Brunetto, AL; Brunetto, AT; da Rocha, A; de Farias, CB; Dos Santos, MP; Dos Santos, RP; Gregianin, LJ; Heinen, TE; Lopez, PL; Rivero, LF; Roesler, R; Silva Filho, MA; Souza, BK	1

Other Studies

1 other study(ies) available for etoposide and staurosporine aglycone

Article	Year
Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma. Oncotarget, 2016, Jun-07, Volume: 7, Issue:23 Topics: Antineoplastic Agents; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Indole Alkaloids; Membrane Glycoproteins; Nerve Growth Factor; Receptor, trkA; Receptor, trkB; RNA, Messenger; Sarcoma, Ewing; Tubulin; Vincristine	2016

Article

Year

Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.

Oncotarget, 2016, Jun-07, Volume: 7, Issue:23

Topics: Antineoplastic Agents; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Indole Alkaloids; Membrane Glycoproteins; Nerve Growth Factor; Receptor, trkA; Receptor, trkB; RNA, Messenger; Sarcoma, Ewing; Tubulin; Vincristine

2016